Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromas, Cutaneous”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Early research (Phase 1)Looking for participantsNCT07102394
What this trial is testing

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Who this might be right for
NF1NeurofibromatosisCutaneous Neurofibroma+3 more
Johns Hopkins University 10
Not applicableStudy completedNCT02777775
What this trial is testing

Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.

Who this might be right for
Cutaneous NeurofibromasNeurofibromatosis Type 1Plexiform Neurofibromas
Corewell Health West 71
Not applicableActive Not RecruitingNCT05581511
What this trial is testing

Natural History Study of Cutaneous Neurofibromas in People With NF1

Who this might be right for
Neurofibromatosis Type 1Neurofibromatosis 1Neurofibromatosis (Nonmalignant)+1 more
Johns Hopkins University 500
Testing effectiveness (Phase 2)Looking for participantsNCT06159166
What this trial is testing

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).

Who this might be right for
NF1Cutaneous NeurofibromaMonotherapy
Johns Hopkins University 24
Early research (Phase 1)Study completedNCT04730583
What this trial is testing

Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

Who this might be right for
Cutaneous Neurofibroma
Massachusetts General Hospital 34
Not applicableUnknownNCT03893643
What this trial is testing

Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15

Who this might be right for
Neurofibromatosis 2Dermatology/Skin - Other
Centre Hospitalier Universitaire de Nice 1,000
Testing effectiveness (Phase 2)Study completedNCT03090971
What this trial is testing

Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1

Who this might be right for
Neurofibromatosis 1Cutaneous Neurofibroma
Fundação Educacional Serra dos Órgãos 7
Testing effectiveness (Phase 2)Looking for participantsNCT02728388
What this trial is testing

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Who this might be right for
NEUROFIBROMATOSIS 1
Donald Basel 30
Early research (Phase 1)Looking for participantsNCT06961565
What this trial is testing

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas

Who this might be right for
NF1 MutationNeurofibroma PlexiformNeurofibroma, Plexiform+2 more
Pasithea Therapeutics Corp. 56
Testing effectiveness (Phase 2)Study completedNCT02332902
What this trial is testing

Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T

Who this might be right for
Neurofibromatosis 1
The University of Texas Health Science Center, Houston 24
Very early researchStudy completedNCT00657202
What this trial is testing

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

Who this might be right for
Neurofibromatosis Type 1Cutaneous Neurofibromas
Massachusetts General Hospital 11
Early research (Phase 1)Study completedNCT01031901
What this trial is testing

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

Who this might be right for
Tuberous SclerosisNeurofibromatosesAngiofibroma+1 more
The University of Texas Health Science Center, Houston 52
Not applicableStudy completedNCT05119582
What this trial is testing

HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy

Who this might be right for
Cutaneous Neurofibroma
Joergen Serup 20
Testing effectiveness (Phase 2)Study completedNCT02839720
What this trial is testing

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis Type 1Optic Nerve Glioma
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868
What this trial is testing

APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Who this might be right for
Unresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more
Ascentage Pharma Group Inc. 230
Large-scale testing (Phase 3)UnknownNCT00921037
What this trial is testing

First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas

Who this might be right for
Cutaneous Neurofibromas
Medical University of Vienna 12
Early research (Phase 1)Study completedNCT06132165
What this trial is testing

Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Who this might be right for
Neurofibromatosis 1
Massachusetts General Hospital 13
Early research (Phase 1)Enrolling By InvitationNCT06300502
What this trial is testing

Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)

Who this might be right for
Neurofibromas, CutaneousNeurofibromatosis 1
Massachusetts General Hospital 15
Not applicableStudy completedNCT00314119
What this trial is testing

Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis Type 1Neurofibroma
National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT06120036
What this trial is testing

Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Who this might be right for
Neurofibromatosis 1
Massachusetts General Hospital 20
Load More Results